Macquarie Group’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-11,000
| Closed | -$212K | – | 1421 |
|
|
2025
Q3 | $212K | Hold |
11,000
| – | – | ﹤0.01% | 1480 |
|
|
2025
Q2 | $188K | Sell |
11,000
-19,690
| -64% | -$840K | ﹤0.01% | 1541 |
|
|
2025
Q1 | $1.96M | Sell |
30,690
-24,843
| -45% | -$2.62M | ﹤0.01% | 1229 |
|
|
2024
Q4 | $6.75M | Buy |
55,533
+16,623
| +43% | +$2.04M | 0.01% | 881 |
|
|
2024
Q3 | $4.86M | Buy |
38,910
+2,319
| +6% | +$321K | 0.01% | 972 |
|
|
2024
Q2 | $5.78M | Buy |
36,591
+12,393
| +51% | +$1.59M | 0.01% | 939 |
|
|
2024
Q1 | $3.13M | Sell |
24,198
-1,718
| -7% | -$210K | ﹤0.01% | 1103 |
|
|
2023
Q4 | $2.5M | Buy |
25,916
+2,156
| +9% | +$207K | ﹤0.01% | 1157 |
|
|
2023
Q3 | $2.88M | Buy |
23,760
+1,972
| +9% | +$223K | ﹤0.01% | 1064 |
|
|
2023
Q2 | $2.5M | Sell |
21,788
-4,336
| -17% | -$559K | ﹤0.01% | 1116 |
|
|
2023
Q1 | $3.6M | Buy |
26,124
+522
| +2% | +$67.7K | ﹤0.01% | 995 |
|
|
2022
Q4 | $3.32M | Sell |
25,602
-6,886
| -21% | -$798K | ﹤0.01% | 1066 |
|
|
2022
Q3 | $3.7M | Sell |
32,488
-5,172
| -14% | -$521K | ﹤0.01% | 1062 |
|
|
2022
Q2 | $2.82M | Buy |
37,660
+236
| +0.6% | +$17.4K | ﹤0.01% | 1179 |
|
|
2022
Q1 | $2.92K | Buy |
37,424
+22,046
| +143% | +$1.69M | ﹤0.01% | 1267 |
|
|
2021
Q4 | $1.39M | Buy |
15,378
+530
| +4% | +$45.3K | ﹤0.01% | 1474 |
|
|
2021
Q3 | $1.37M | Sell |
14,848
-163,720
| -92% | -$12.6M | ﹤0.01% | 1500 |
|
|
2021
Q2 | $13.9M | Buy |
178,568
+164,586
| +1,177% | +$12.5M | 0.01% | 862 |
|
|
2021
Q1 | $1.04M | Sell |
13,982
-627,300
| -98% | -$57.9M | ﹤0.01% | 1389 |
|
|
2020
Q4 | $109M | Buy |
641,282
+98,220
| +18% | +$14.6M | 0.16% | 143 |
|
|
2020
Q3 | $76.3M | Buy |
543,062
+14,075
| +3% | +$2.14M | 0.13% | 166 |
|
|
2020
Q2 | $84.8M | Buy |
528,987
+505,065
| +2,111% | +$68.7M | 0.15% | 144 |
|
|
2020
Q1 | $2.34M | Hold |
23,922
| – | – | ﹤0.01% | 877 |
|
|
2019
Q4 | $3.09M | Buy |
23,922
+922
| +4% | +$93.1K | ﹤0.01% | 925 |
|
|
2019
Q3 | $1.73M | Sell |
23,000
-341,424
| -94% | -$40.3M | ﹤0.01% | 1074 |
|
|
2019
Q2 | $55.4M | Buy |
364,424
+14,327
| +4% | +$1.74M | 0.09% | 228 |
|
|
2019
Q1 | $41.7M | Sell |
350,097
-146,769
| -30% | -$18.9M | 0.07% | 290 |
|
|
2018
Q4 | $54.2M | Sell |
496,866
-18,086
| -4% | -$2.26M | 0.1% | 192 |
|
|
2018
Q3 | $83.2M | Buy |
514,952
+131,859
| +34% | +$18M | 0.14% | 136 |
|
|
2018
Q2 | $50.6M | Buy |
383,093
+312,670
| +444% | +$29.5M | 0.09% | 234 |
|
|
2018
Q1 | $5.22M | Buy |
70,423
+47,423
| +206% | +$3.16M | 0.01% | 738 |
|
|
2017
Q4 | $1.28M | Sell |
23,000
-10,000
| -30% | -$530K | ﹤0.01% | 1174 |
|
|
2017
Q3 | $1.5M | Hold |
33,000
| – | – | ﹤0.01% | 1076 |
|
|
2017
Q2 | $1.11M | Hold |
33,000
| – | – | ﹤0.01% | 1134 |
|
|
2017
Q1 | $977K | Hold |
33,000
| – | – | ﹤0.01% | 1190 |
|
|
2016
Q4 | $905K | Buy |
+33,000
| New | +$1.33M | ﹤0.01% | 1182 |
|
|
2016
Q2 | – | Sell |
-45,362
| Closed | -$885K | – | 1636 |
|
|
2016
Q1 | $885K | Buy |
45,362
+6,829
| +18% | +$119K | ﹤0.01% | 1149 |
|
|
2015
Q4 | $1.49M | Sell |
38,533
-20,708
| -35% | -$671K | ﹤0.01% | 1005 |
|
|
2015
Q3 | $1.9M | Sell |
59,241
-30,759
| -34% | -$1.04M | ﹤0.01% | 984 |
|
|
2015
Q2 | $2.74M | Buy |
90,000
+42,000
| +88% | +$859K | 0.01% | 946 |
|
|
2015
Q1 | $637K | Hold |
48,000
| – | – | ﹤0.01% | 1230 |
|
|
2014
Q4 | $695K | Buy |
48,000
+5,000
| +12% | +$84.7K | ﹤0.01% | 1215 |
|
|
2014
Q3 | $907K | Buy |
43,000
+7,000
| +19% | +$158K | ﹤0.01% | 1179 |
|
|
2014
Q2 | $1.07M | Hold |
36,000
| – | – | ﹤0.01% | 1190 |
|
|
2014
Q1 | $865K | Hold |
36,000
| – | – | ﹤0.01% | 1187 |
|
|
2013
Q4 | $733K | Buy |
36,000
+17,000
| +89% | +$505K | ﹤0.01% | 1212 |
|
|
2013
Q3 | $897K | Sell |
19,000
-3,000
| -14% | -$116K | ﹤0.01% | 1192 |
|
|
2013
Q2 | $837K | Buy |
+22,000
| New | +$787K | ﹤0.01% | 1185 |
|
Other funds holding SRPT
EAM
